Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Selective progesterone receptor modulators.

Whitaker LH, Williams AR, Critchley HO.

Curr Opin Obstet Gynecol. 2014 Aug;26(4):237-42. doi: 10.1097/GCO.0000000000000082. Review.

PMID:
24950125
2.
3.
4.

Selective progesterone receptor modulators: an update.

Benagiano G, Bastianelli C, Farris M, Brosens I.

Expert Opin Pharmacother. 2014 Jul;15(10):1403-15. doi: 10.1517/14656566.2014.914494. Epub 2014 Apr 30. Review.

PMID:
24787486
5.

Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety.

Bouchard P, Chabbert-Buffet N, Fauser BC.

Fertil Steril. 2011 Nov;96(5):1175-89. doi: 10.1016/j.fertnstert.2011.08.021. Epub 2011 Sep 23.

PMID:
21944187
6.

Clinical utility of progesterone receptor modulators and their effect on the endometrium.

Spitz IM.

Curr Opin Obstet Gynecol. 2009 Aug;21(4):318-24. doi: 10.1097/GCO.0b013e32832e07e8. Review.

PMID:
19602929
7.

Ulipristal acetate for uterine fibroid-related symptoms.

Puchar A, Luton D, Koskas M.

Drugs Today (Barc). 2015 Nov;51(11):661-7. doi: 10.1358/dot.2015.51.11.2413469. Review.

PMID:
26744741
8.

Ulipristal acetate: a novel option for the medical management of symptomatic uterine fibroids.

Talaulikar VS, Manyonda IT.

Adv Ther. 2012 Aug;29(8):655-63. doi: 10.1007/s12325-012-0042-8. Epub 2012 Aug 16. Review.

PMID:
22903240
9.

[Selective progesterone receptor modulators and their therapeutical use].

Driák D, Sehnal B, Svandová I.

Ceska Gynekol. 2013 Apr;78(2):175-81. Czech.

PMID:
23710982
10.

Individualized vaginal bleeding experience of women with uterine fibroids in the PEARL I randomized controlled trial comparing the effects of ulipristal acetate or placebo.

Barlow DH, Lumsden MA, Fauser BC, Terrill P, Bestel E.

Hum Reprod. 2014 Mar;29(3):480-9. doi: 10.1093/humrep/det467. Epub 2014 Jan 23.

11.

Drug safety evaluation of ulipristal acetate in the treatment of uterine fibroids.

Tafi E, Scala C, Leone Roberti Maggiore U, Bizzarri N, Candiani M, Venturini PL, Ferrero S.

Expert Opin Drug Saf. 2015 Jun;14(6):965-77. doi: 10.1517/14740338.2015.1021773. Epub 2015 Mar 14. Review.

PMID:
25772793
12.

Ulipristal acetate in the management of symptomatic uterine fibroids: facts and pending issues.

Pérez-López FR.

Climacteric. 2015 Apr;18(2):177-81. doi: 10.3109/13697137.2014.981133. Epub 2014 Nov 12. Review.

PMID:
25390187
13.

Endometrial changes from short-term therapy with CDB-4124, a selective progesterone receptor modulator.

Ioffe OB, Zaino RJ, Mutter GL.

Mod Pathol. 2009 Mar;22(3):450-9. doi: 10.1038/modpathol.2008.204. Epub 2009 Jan 9.

14.

Ulipristal acetate for use in moderate to severe symptoms of uterine fibroids.

Talaulikar VS, Manyonda I.

Womens Health (Lond). 2014 Nov;10(6):565-70. doi: 10.2217/whe.14.60.

PMID:
25482483
15.

[Ulipristal acetate, 5mg: a new alternative].

Monleón Sancho J, Romaguera E, Romero A, Higueras G, Morcillo I, Fuster S.

Med Clin (Barc). 2013 Jul;141 Suppl 1:40-6. doi: 10.1016/S0025-7753(13)70052-6. Review. Spanish.

PMID:
24314567
16.

Ulipristal acetate versus placebo for fibroid treatment before surgery.

Donnez J, Tatarchuk TF, Bouchard P, Puscasiu L, Zakharenko NF, Ivanova T, Ugocsai G, Mara M, Jilla MP, Bestel E, Terrill P, Osterloh I, Loumaye E; PEARL I Study Group.

N Engl J Med. 2012 Feb 2;366(5):409-20. doi: 10.1056/NEJMoa1103182.

17.

Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis.

Chwalisz K, Perez MC, Demanno D, Winkel C, Schubert G, Elger W.

Endocr Rev. 2005 May;26(3):423-38. Epub 2005 Apr 27. Review. Erratum in: Endocr Rev. 2005 Aug;26(5):703.

PMID:
15857972
18.

With the advent of selective progesterone receptor modulators, what is the place of myoma surgery in current practice?

Donnez J, Donnez O, Dolmans MM.

Fertil Steril. 2014 Sep;102(3):640-8. doi: 10.1016/j.fertnstert.2014.06.041. Epub 2014 Aug 5. Review.

PMID:
25106762
19.

Current and future medical treatments for menometrorrhagia during the premenopause.

Bouchard P.

Gynecol Endocrinol. 2011 Dec;27 Suppl 1:1120-5. doi: 10.3109/09513590.2012.638754. Review.

PMID:
22182055
20.

Endometrial morphology after treatment of uterine fibroids with the selective progesterone receptor modulator, ulipristal acetate.

Williams AR, Bergeron C, Barlow DH, Ferenczy A.

Int J Gynecol Pathol. 2012 Nov;31(6):556-69. doi: 10.1097/PGP.0b013e318251035b.

PMID:
23018219
Items per page

Supplemental Content

Write to the Help Desk